<Version><xmlsource>This XML content was developed by AHRQ's contractor ECRI Institute for the National Guideline Clearinghouse (NGC).</xmlsource><Section SecID="390" OrdBy="100" Name="General"><Field FieldID="161" OrdBy="105" ID="391" Name="Guideline Title" Type="text"><FieldValue Value="&lt;div class=&quot;content_title&quot;&gt;Managing complications. In: Clinical guidelines for stroke management 2010.&lt;/div&gt;" /></Field><Field FieldID="97" OrdBy="110" ID="392" Name="Bibliographic Source(s)" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Managing complications. In: Clinical guidelines for stroke management 2010. Melbourne (Australia): National Stroke Foundation; 2010 Sep. p. 96-111.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="120" OrdBy="115" ID="393" Name="Guideline Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the guideline.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;This guideline updates a previous version: Prevention and management of complications. In: National Stroke Foundation. Clinical guidelines for acute stroke management. Melbourne (Australia): National Stroke Foundation; 2007 Oct. p. 39-42.&lt;/p&gt;&lt;/div&gt;" /></Field><Field Name ="UMLS Concepts"><FieldValue Value="HCPCS: Continuous positive airway pressure (cpap) device ; Incontinence garment, any type, (e.g. brief, diaper), each ; Incontinence supply; miscellaneous "/><FieldValue Value="ICD9CM: Behavior therapy  (94.33); Cerebral artery occlusion, unspecified with cerebral infarction  (434.91); Cerebral artery occlusion, unspecified without mention of cerebral infarction  (434.90); Cerebral edema  (348.5); Contracture of joint, site unspecified  (718.40); Edema  (782.3); Fever, unspecified  (780.60); Neurologic examination  (89.13); Organic sleep apnea, unspecified  (327.20); Pressure ulcer, unspecified site  (707.00); Retention of urine, unspecified  (788.20); Unspecified intracranial hemorrhage  (432.9); Unspecified sleep apnea  (780.57); Urge incontinence  (788.31); Urinary incontinence, unspecified  (788.30)"/><FieldValue Value="MSH: Accidental Falls ; Acetaminophen ; Adrenal Cortex Hormones ; Anticonvulsants ; Antidepressive Agents ; Antidepressive Agents, Tricyclic ; Beds ; Behavior Therapy ; Botulinum Toxins, Type A ; Brain Edema ; Brain Ischemia ; Casts, Surgical ; Catheters, Indwelling ; Cholinergic Antagonists ; Continuous Positive Airway Pressure ; Contracture ; Craniotomy ; Depression ; Diapers, Adult ; Diuretics, Osmotic ; Early Ambulation ; Edema ; Electric Stimulation Therapy ; Enteral Nutrition ; Exercise ; Exercise Therapy ; Fatigue ; Fecal Incontinence ; Fever ; Fluid Therapy ; Heparin, Low-Molecular-Weight ; Hypothermia, Induced ; Incontinence Pads ; Inservice Training ; Intracranial Hemorrhages ; Motion Therapy, Continuous Passive ; Muscle Spasticity ; Neurologic Examination ; Oral Hygiene ; Orthotic Devices ; Pain Management ; Patient Care Team ; Patient Education as Topic ; Platelet Aggregation Inhibitors ; Pressure Ulcer ; Pulmonary Embolism ; Referral and Consultation ; Respiratory Therapy ; Risk Assessment ; Shoulder Dislocation ; Shoulder Pain ; Sleep Apnea Syndromes ; Stockings, Compression ; Stroke ; Thrombolytic Therapy ; Urinary Catheterization ; Urinary Catheters ; Urinary Incontinence ; Urinary Incontinence, Urge ; Urinary Retention ; Venous Thrombosis "/><FieldValue Value="MTH: Accidental Falls ; Acetaminophen ; Adrenal Cortex Hormones ; Anticonvulsants ; Antidepressive Agents ; Beds ; Behavior Disorders ; Botulinum Toxin Type A ; Bowel training (regime/therapy) ; Brain Edema ; Brain hemorrhage ; Brain Ischemia ; Cerebral Edema ; Cerebrovascular accident ; Cholinergic Antagonists ; Compression Stockings ; Continuous Positive Airway Pressure ; Contracture ; Dental Hygiene ; Diuretics, Osmotic ; edema ; Electric Stimulation Therapy ; Enteral Nutrition ; Exercise ; Fall prevention ; Fatigue ; Fecal Incontinence ; Fever ; Fluid Therapy ; Heparin, Low-Molecular-Weight ; Hypothermia, Induced ; Incontinence pads ; Indwelling Catheter ; Inservice Training ; Ischemic stroke ; Mental Depression ; Muscle Spasticity ; Nasogastric tube ; Neurologic Examination ; Orthotic Devices ; Pain management ; Patient education (procedure) ; Physical therapy exercises ; Platelet Aggregation Inhibitors ; Pressure Ulcer ; Pulmonary Embolism ; Respiratory Therapy ; Risk Assessment ; Shoulder Pain ; Shoulder strapping ; Sleep Apnea Syndromes ; Special care of mouth ; Tricyclic Antidepressive Agents ; Urge Incontinence ; Urinary bladder training ; Urinary catheter ; Urinary Catheterization ; Urinary Incontinence ; Urinary Retention ; Venous Thrombosis "/><FieldValue Value="PDQ: acetaminophen ; cerebral edema ; fatigue ; fatigue assessment/management ; fecal incontinence ; pain therapy ; thrombolytic therapy ; urinary incontinence "/><FieldValue Value="SNOMEDCT_US: Accidental fall  (217082002); Acetaminophen  (387517004); Acetaminophen  (90332006); Anticonvulsant  (255632006); Anticonvulsant  (63094006); Antidepressant  (36236003); Antidepressant  (372720008); Bed  (229772003); Behavioral therapy  (166001); Biofeedback system  (40432008); Biofeedback system  (466651006); Botulinum toxin type A  (108890005); Botulinum toxin type A  (427412002); Bowel training  (385976008); Cerebral artery occlusion  (20059004); Cerebral edema  (2032001); Cerebrovascular accident  (230690007); Compression stocking  (348681001); Compression stocking  (467848007); Continuing positive airway pressure unit  (37874008); Continuous passive motion therapy  (229078009); Continuous positive airway pressure ventilation treatment  (47545007); Contracture  (55033002); Contracture  (57048009); Contracture of joint  (7890003); Corticoid preparation  (21568003); Corticoid preparation  (79440004); Craniotomy  (25353009); Depression management program  (401174001); Dislocation of shoulder joint  (125615005); Dislocation of shoulder joint  (417076003); Edema  (20741006); Edema  (267038008); Edema  (423666004); Edema  (79654002); Education of caregiver  (427519008); Education of caregiver  (460617003); Electromyographic biofeedback  (36430006); Exercise  (183301007); Exercise  (256235009); Exercise  (61686008); Fall prevention  (386296001); Fatigue  (248274002); Fatigue  (84229001); Fever  (386661006); Fever  (50177009); Food and drink intake  (229918000); Incontinence of feces  (72042002); Induction of hypothermia  (308693008); Insertion of appliance for sleep apnea  (234825004); Intracranial hemorrhage  (1386000); Ischemic encephalopathy  (389100007); Ischemic stroke  (422504002); Limb exsanguination by gravity  (310486006); Low molecular weight heparin  (373294004); Low molecular weight heparin  (87233003); Nasogastric tube  (17102003); Neurological assessment  (225398001); Neurological assessment  (84728005); O/E - muscle contracture  (163656006); Oral hygiene status  (110298001); Oral hygiene status  (364126007); Organic sleep apnea  (442164004); Orthotic device  (224898003); Osmotic diuretic  (372792005); Osmotic diuretic  (59799001); Pain management  (278414003); Patient education  (311401005); Pressure garments  (360009006); Pressure relief equipment  (360302009); Pressure ulcer  (399912005); Pressure ulcer  (420226006); Pressure ulcer risk assessment  (225392000); Pulmonary embolism  (59282003); Pulmonary embolism with pulmonary infarction  (1001000119102); Respiratory therapy  (53950000); Retention of urine  (130951007); Retention of urine  (267064002); Risk assessment  (225338004); Shoulder pain  (45326000); Shoulder strapping  (229535006); Sleep apnea  (73430006); Spasticity  (221360009); Spasticity  (397790002); Special care of mouth  (4496006); Subluxation of shoulder joint  (263051004); Therapeutic electrical stimulation  (169430000); Therapeutic electrical stimulation  (57942008); Therapeutic exercise  (226029000); Therapeutic exercise  (229065009); Therapeutic exercise  (51998003); Thrombolytic therapy  (426347000); Tricyclic antidepressant  (33219003); Tricyclic antidepressant  (373253007); Urge incontinence of urine  (87557004); Urinary bladder training  (37799002); Urinary catheter  (20568009); Urinary incontinence  (165232002); Urinary incontinence care management  (408979003); Venous thrombosis  (111293003)"/><FieldValue Value="SPN: DEVICE, BIOFEEDBACK ; MATTRESS, AIR FLOTATION, ALTERNATING PRESSURE ; STOCKING, MEDICAL SUPPORT (FOR GENERAL MEDICAL PURPOSES) ; TUBE, NASOGASTRIC "/><FieldValue Value="UMD: Beds  (10-342); Biofeedback Systems  (10-396); Cast Material  (10-665); Catheters, Urinary  (10-764); Cooling Units, Patient  (12-078); Diapers, Adult  (11-239); Exercisers, Continuous Passive Motion, Lower Limb  (17-138); Exercisers, Continuous Passive Motion, Upper Limb  (17-139); Exercisers, Continuous Passive/Active Motion, Lower/Upper Limb  (23-744); Mattress Systems, Alternating-Pressure  (18-147); Orthoses  (12-837); Orthoses, Upper Limb, Arm  (17-872); Positive Airway Pressure Units, Continuous  (11-001); Procedure Kit/Trays, Catheterization, Urinary, Intermittent  (16-321); Socks/Stockings, Elastic Compression  (13-789); Tubes, Nasogastric  (14-221)"/></Field></Section><Section SecID="396" OrdBy="300" Name="Scope"><Field FieldID="140" OrdBy="305" ID="397" Name="Disease/Condition(s)" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Stroke &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Transient ischaemic attack (TIA) &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: These guidelines do not cover:&lt;/p&gt;&#xD;&#xA;&lt;ul class=&quot;contentListFont&quot;&gt;&#xD;&#xA;    &lt;li&gt;Subarachnoid haemorrhage &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Stroke in infants, children and youth (i.e., &amp;lt;18 years old), or &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Primary prevention of stroke (refer to Guidelines for the assessment of absolute cardiovascular disease risk 2009) &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field><Field FieldID="103" OrdBy="310" ID="398" Name="Guideline Category" Type="picklist-many"><FieldValue Value="Counseling" /><FieldValue Value="Evaluation" /><FieldValue Value="Management" /><FieldValue Value="Prevention" /><FieldValue Value="Risk Assessment" /></Field><Field FieldID="113" OrdBy="315" ID="399" Name="Clinical Specialty" Type="picklist-many"><FieldValue Value="Family Practice" /><FieldValue Value="Internal Medicine" /><FieldValue Value="Neurology" /><FieldValue Value="Nursing" /><FieldValue Value="Nutrition" /><FieldValue Value="Physical Medicine and Rehabilitation" /><FieldValue Value="Preventive Medicine" /><FieldValue Value="Psychiatry" /><FieldValue Value="Psychology" /><FieldValue Value="Urology" /></Field><Field FieldID="114" OrdBy="320" ID="400" Name="Intended Users" Type="picklist-many"><FieldValue Value="Advanced Practice Nurses" /><FieldValue Value="Dietitians" /><FieldValue Value="Nurses" /><FieldValue Value="Occupational Therapists" /><FieldValue Value="Physical Therapists" /><FieldValue Value="Physician Assistants" /><FieldValue Value="Physicians" /></Field><Field FieldID="129" OrdBy="325" ID="401" Name="Guideline Objective(s)" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;To provide evidence-based recommendations related to recovery from stroke and transient ischaemic attack (TIA) to assist decision-making based on the best evidence available at the time of development&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="132" OrdBy="330" ID="402" Name="Target Population" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Adults (18 years or older) with stroke or transient ischemic attack (TIA) symptoms&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="133" OrdBy="335" ID="403" Name="Interventions and Practices Considered" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Management/Prevention&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Monitoring of food intake &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Nasogastric tube feeding &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Fluid supplementation &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Assistance and education to maintain good oral hygiene &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Training of staff/carers to provide oral hygiene &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Reduction of spasticity (electrical stimulation, electromyographic biofeedback, botulinum toxin A) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Contracture management (early tailored interventions, serial casting) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Measures for prevention and management of shoulder subluxation (electrical stimulation, support devices) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Shoulder strapping for prevention of shoulder pain &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Management of central post-stroke pain (tricyclic antidepressants, anticonvulsants) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Referral to specialist pain management team as indicated &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Measures to prevent swelling of the hands and feet (dynamic pressure garments, limb elevation, continuous passive motion) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Training to increase cardiorespiratory fitness &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Education of patients and carers about management strategies &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Fatigue management (timing of daily therapy) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Measures for management of urinary incontinence (continence management plan, referral to specialist) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Urge incontinence (anticholinergic agents, scheduled voiding/bladder retraining, containment aids) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Urinary retentions (intermittent/indwelling catheterisation) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Measures for management of faecal incontinence (bowel habit retraining, containment aids) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Psychological strategies to prevent depression &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Management of depression (antidepressants &amp;amp; cognitive behavioural therapy) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Rehabilitation support for behavioural changes &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Prevention and prophylaxis for deep venous thrombosis and pulmonary embolism &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Pressure relief aids &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Prevention of falls (personal and community interventions including exercise program) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Management of sleep apnoea &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&lt;/div&gt;" /></Field><Field FieldID="134" OrdBy="340" ID="404" Name="Major Outcomes Considered" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Stroke complications &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Functional status &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field></Section><Section SecID="405" OrdBy="400" Name="Methodology"><Field FieldID="109" OrdBy="405" ID="406" Name="Methods Used to Collect/Select the Evidence" Type="picklist-many"><FieldValue Value="Hand-searches of Published Literature (Primary Sources)" /><FieldValue Value="Hand-searches of Published Literature (Secondary Sources)" /><FieldValue Value="Searches of Electronic Databases" /></Field><Field FieldID="135" OrdBy="410" ID="407" Name="Description of Methods Used to Collect/Select the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Finding Relevant Studies&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Systematic identification of relevant studies was conducted between May and August 2009. An external consultant undertook all the electronic database searches. EMBASE, Medline and Cochrane databases were used for all questions. CINAHL and PsycINFO databases were searched where relevant (e.g., questions relating to rehabilitation, discharge planning or long-term recovery). The PEDro database was used by the National Stroke Foundation (NSF) project team to check studies related to physical therapy. A second updated search of the literature up to February 19, 2010 using Medline and EMBASE databases was conducted. Updated Cochrane reviews were also searched and included.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Where the questions were the same as those used in the previous acute management guidelines (2007), the literature was searched from the beginning of 2007. Where the questions were the same as those used in the previous rehabilitation guidelines (2005), the literature was searched from the beginning of 2005. For topics not previously addressed, searches were carried out from 1966 onwards.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Searching of EMBASE, Medline and Cochrane libraries was conducted in four broad steps:&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Terms for the patient group were abridged from the Cochrane Collaboration's Stroke Group. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;A second search term specific to the particular question (i.e., specific terms relevant to an intervention or assessment) was added. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Relevant evidence filters (Cochrane sensitive filter or Medline diagnostic filter) were applied. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;If the search was for an update to an authoritative meta-analysis (NSF or other), it was limited to the years after the relevant document was published. &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;Search strategies are available from the NSF. Table A2.1 in the original guideline document outlines the number of articles found for each of the nine broad topic areas.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;A total of 39,930 potential articles were identified up until August 2009 and an additional 7337 at February 2010. Reference lists of identified articles and other guidelines were then used to identify further studies. Existing international guidelines identified and used included those published by the Scottish Intercollegiate Guidelines Network (SIGN), the National Institute for Health and Clinical Excellence UK, the Royal College of Physicians (London, UK), the Canadian Stroke Network and the Heart and Stroke Foundation of Canada, the American Heart/Stroke Association and the European Stroke Organisation. Correspondence with SIGN identified overlapping topics that had recently been systematically searched by SIGN and hence this information was kindly provided and used for several rehabilitation-related topics. A number of key journals were also searched by hand from October 2009 to March 2010: &lt;em&gt;Stroke, Cerebrovascular Disease, Lancet (&lt;/em&gt;and &lt;em&gt;Lancet Neurology),&lt;/em&gt; and &lt;em&gt;Archives of Physical Medicine and Rehabilitation&lt;/em&gt;. Further, an internet search was undertaken (using the 'Google' search engine). Finally, where possible, experts in the field were contacted to review the identified studies and suggest other new studies not yet identified.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;One reviewer initially scanned the titles and available abstracts of all studies identified by the searches and excluded any clearly irrelevant studies. Based on the titles and abstracts of the remaining studies, two reviewers assessed and selected potentially eligible studies using the following inclusion criteria:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Type of study. Relevant systematic reviews were first identified. Where no systematic review was found, randomized controlled trials (RCTs) were searched. If there was a sparsity of Level I or Level II evidence, the search was expanded to consider lower levels of evidence. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Type of participant. Initially only studies which included adults (&amp;gt;18 years) with stroke or transient ischaemic attack (TIA) were included. Studies in other related populations (e.g., general elderly population or those with traumatic brain injury) were then included if the particular intervention was deemed to be transferable to those with stroke. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Language. Only studies published in English were used. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;Disagreements on inclusion of particular studies were resolved by consensus. If necessary a relevant member of the expert working group (EWG) provided a third and final vote.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;In addition to the initial searches, economic literature was searched via the Australian Medical Index, Econlit, EMBASE, Medline, Health Technology Assessment, and National Health Service (NHS) Economic Evaluation Databases. Searches were carried out from the beginning of 2005 to identify papers published after the rehabilitation guidelines (2005). A total of 1033 references were retrieved after de-duplication (Table A2.2 in the original guideline document). One person initially reviewed all references and selected 44 potentially relevant articles. These abstracts were scrutinised by two people and 35 appropriate papers were retrieved and reviewed.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="136" OrdBy="415" ID="408" Name="Number of Source Documents" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;35 appropriate papers were retrieved.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="115" OrdBy="420" ID="409" Name="Methods Used to Assess the Quality and Strength of the Evidence" Type="picklist-choice"><FieldValue Value="Expert Consensus" /><FieldValue Value="Weighting According to a Rating Scheme (Scheme Given)" /></Field><Field FieldID="149" OrdBy="425" ID="410" Name="Rating Scheme for the Strength of the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Designation of Levels of Evidence According to Type of Research Question&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;table border=&quot;1&quot; cellspacing=&quot;1&quot; summary=&quot;Designation of Levels of Evidence According to Type of Research Question&quot; cellpadding=&quot;3&quot;&gt;&#xD;&#xA;    &lt;thead&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Level&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Intervention&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Diagnosis&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Prognosis&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Aetiology&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Screening&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/thead&gt;&#xD;&#xA;    &lt;tbody&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;I&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A systematic review of Level II studies&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A systematic review of Level II studies&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A systematic review of Level II studies&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A systematic review of Level II studies&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A systematic review of Level II studies&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;II&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A randomised controlled trial&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A study of test accuracy with: an independent, blinded comparison with a valid reference standard, among consecutive patients with a defined clinical presentation&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A prospective cohort study&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A prospective cohort study&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A randomised controlled trial&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;III-1&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A pseudo-randomised controlled trial (i.e., alternate allocation or some other method)&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A study of test accuracy with: an independent, blinded comparison with a valid reference standard, among consecutive patients with a defined clinical presentation&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;All or none&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;All or none&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A pseudo-randomised controlled trial (i.e., alternate allocation or some other method)&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;III-2&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A comparative study with concurrent controls:&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;Non-randomised experimental trial &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Cohort study &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Case-control study &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Interrupted time series without a parallel control group &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A comparison with a reference standard that does not meet the criteria required for Level II and Level III-1 evidence&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Analysis of prognostic factors amongst untreated control patients in a randomised controlled trial&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A retrospective cohort study&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A comparative study with concurrent controls:&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;Nonrandomised, experimental trial &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Cohort study &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Case-control study &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;III-3&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A comparative study without concurrent controls:&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;Historical control study &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Two or more single arm studies &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Interrupted time series without a parallel control group &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Diagnostic case-control study&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A retrospective cohort study&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A case-control study&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A comparative study without concurrent controls:&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;Historical control study &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Two or more single arm studies &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;IV&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Case series with either post-test or pre-test/post-test outcomes&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Study of diagnostic yield (no reference standard)&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Case series or cohort study of patients at different stages of disease&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A cross-sectional study&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Case series&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/tbody&gt;&#xD;&#xA;&lt;/table&gt;&lt;/div&gt;" /></Field><Field FieldID="116" OrdBy="430" ID="411" Name="Methods Used to Analyze the Evidence" Type="picklist-many"><FieldValue Value="Review of Published Meta-Analyses" /><FieldValue Value="Systematic Review with Evidence Tables" /></Field><Field FieldID="150" OrdBy="435" ID="412" Name="Description of the Methods Used to Analyze the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Appraising the Selected Studies&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;A standardised appraisal process was used based on forms adapted from the Guidelines International Network and Scottish Intercollegiate Guideline Network (SIGN). Where available, appraisals already undertaken by SIGN for the rehabilitation section were used to avoid duplication. The standardised appraisal form assesses the level of evidence (design and issues of quality), size of effect, relevance, applicability (benefits/harms) and generalisability of studies. Examples of completed checklists can be obtained from the National Stroke Foundation (NSF). Evidence for diagnostic and prognostic studies was also appraised using the SIGN methodology.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Summarising and Synthesising the Evidence&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Details of relevant studies were summarised in evidence tables which form a supplement to this document and can be downloaded from the NSF website (&lt;a href=&quot;http://www.strokefoundation.com.au/&quot; title=&quot;NSF Australia Web site&quot;&gt;www.strokefoundation.com.au&lt;/a&gt;).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;To assist in the formulation of recommendations for each question, the National Health and Medical Research Council (NMHRC) Grades process (2008&amp;ndash;2010) was applied. No pooling of data or meta-analysis was undertaken during the evidence synthesis process.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="112" OrdBy="440" ID="413" Name="Methods Used to Formulate the Recommendations" Type="picklist-choice"><FieldValue Value="Expert Consensus" /><FieldValue Value="Informal Consensus" /></Field><Field FieldID="145" OrdBy="445" ID="414" Name="Description of Methods Used to Formulate the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;These guidelines were developed according to standards outlined by the National Health and Medical Research Council (NHMRC).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Question Formulation&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Clinical questions used for previous guidelines were reviewed and duplication removed. A draft set of questions was developed by the National Stroke Foundation (NSF) project team and circulated to the expert working group (EWG). The EWG agreed on one hundred and thirty-four (134) specific clinical questions addressing interventions relevant to stroke care. The questions generally queried the effects of a specific intervention and were developed in three parts: the intervention, the outcomes and the population, for example, 'What is the effect of anticonvulsant therapy on reducing seizures in people with post-stroke seizures?' In this example, anticonvulsant therapy is the intervention, reduction of post-stroke seizures is the outcome, and the population is people with post-stroke seizures. The list of questions is available from the NSF.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Summarising and Synthesising the Evidence&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For each question, the NSF project team developed a draft recommendation based on the NHMRC matrix (Table A2.3 in the original guideline document). These recommendations were subsequently discussed and agreed on by the EWG. Final decisions were made by informal group processes after open discussion facilitated by the co-chairs. The recommended grading matrix was used to guide the strength or grading of the recommendation (Table A2.4 in the original guideline document).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Following agreement on recommendations, the NSF project team drafted the body of the guidelines which included a brief discussion of the evidence and other relevant factors such as the current gaps in practice as outlined in the most recent National Stroke Audits or considerations regarding implementation. Early drafts were circulated for comment by the EWG and amended before release for public consultation.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="146" OrdBy="450" ID="415" Name="Rating Scheme for the Strength of the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Grading of Recommendations&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;table border=&quot;1&quot; cellspacing=&quot;1&quot; summary=&quot;Table: Grades of Recommendations&quot; cellpadding=&quot;3&quot;&gt;&#xD;&#xA;    &lt;thead&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Grade&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Description&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/thead&gt;&#xD;&#xA;    &lt;tbody&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;A&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Body of evidence can be trusted to guide practice&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;B&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Body of evidence can be trusted to guide practice in most situations&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;C&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Body of evidence provides some support for recommendation(s) but care should be taken in its application&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;D&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Body of evidence is weak and recommendation must be applied with caution&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Good Practice Point (GPP)&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Recommended best practice based on clinical experience and expert opinion&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/tbody&gt;&#xD;&#xA;&lt;/table&gt;&lt;/div&gt;" /></Field><Field FieldID="148" OrdBy="460" ID="417" Name="Cost Analysis" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Cost and Socioeconomic Implications&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The lifetime costs of first-ever stroke have been recently estimated to be more than $2 billion in Australia (net present value 2004). Therefore, providing cost-effective stroke care (prevention management and treatment) is important to avoid unnecessary costs to society. This section presents an updated review of the cost and socioeconomic implications of providing evidence-based stroke care given the recommendations within these guidelines. The expert working group (EWG) (including a search specialist) conducted a separate systematic review for this section. A broad search strategy was used to search the following databases: Econlit, EMBASE, Medline, Health Technology Assessment, National Health Service (NHS) Evaluations and Australasian Medical Index (the search strategy used is available from the National Stroke Foundation). The search yielded 1033 abstracts which were reviewed by one member of the project team. Forty-four potential studies were selected for further consideration.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Staff at the National Stroke Research Institute, a subsidiary of Florey Neuroscience Institutes, scrutinised the 44 abstracts published between 2005 and 2009 for omissions and appropriate papers were retrieved and reviewed. As the breadth of topics was wide and the methods used quite disparate, a narrative review was deemed the most appropriate way to summarise the cost and socioeconomic evidence. There was also a preference to report evidence from studies undertaken in Australia. Therefore, if similar work had been undertaken elsewhere, this information was not included in the summary unless the results were relevant to the findings in Australia. This is because it is often difficult to extrapolate from international studies to the Australian context given differences in health services provision and funding, target populations and interventions such as drug dosages.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The discussion related to the cost-effectiveness evidence is presented to follow the structure of the guidelines document. It should be noted that these guidelines include several consensus recommendations or recommendations based on levels of evidence below Level II for a number of 'micro' clinical practice issues (e.g., physiological monitoring and oxygen therapy). As such, it is not possible to analyse the implications of these sorts of recommendations, as they in fact often form part of a larger package or program of care for which there is Level I evidence (for example, stroke units). Furthermore, there is limited cost-effectiveness evidence available for many acute stroke care interventions and often these types of studies have not been conducted. Therefore, evidence and discussion for the main (strongest) recommendations in these guidelines is provided. This review is also an extension of the summaries provided in the earlier versions of the stroke clinical guidelines.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Conclusions&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;There is good cost-effectiveness evidence for the most clinically effective stroke prevention and treatment strategies recommended in these guidelines. In particular, stroke unit care, thrombolysis, blood pressure lowering, warfarin for atrial fibrillation (AF), aspirin for stroke prevention and carotid endarterectomy were all determined to be worthwhile from an economic perspective. The findings for intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) administered within three hours of acute ischaemic stroke were consistently found to be cost-saving from a lifetime perspective. However, there is limited evidence for the cost-effectiveness of rt-PA used up to 4.5 hours and further research is needed. There is sufficient evidence for the cost-effectiveness of antithrombotic therapy with dipyridamole plus aspirin compared to aspirin alone in secondary stroke prevention. There is also sufficient evidence for blood pressure lowering with angiotensin-converting enzyme (ACE) inhibitors in all stroke and transient ischaemic attack (TIA) patients, as recommended by these guidelines. This review also allowed the developers to identify a range of areas where additional cost-effectiveness studies would complement health outcome data, including an assessment of home-based stroke rehabilitation, rapid assessment clinics for TIA, carer training, the use of botulinum toxin A for stroke patients with persistent moderate to severe spasticity and imaging modalities for selecting patients for intravenous thrombolysis. One major factor that may influence the economic implications of interventions found to be cost-effective is access and population coverage. In a recent modelling exercise in the Australian setting, it was found that more widely accessible, evidence-based stroke care could produce substantial economic and health-related benefits and would require only modest investment. The authors suggested that if there was improved access to effective acute care (stroke units and intravenous thrombolysis) and secondary prevention (BP lowering, warfarin for AF, aspirin in ischaemic stroke and carotid endarterectomy) and improved management of BP and AF as primary prevention in the Australian population, then about $1.06 billion could be recovered as potential cost-offsets with recovery of more than 85,000 DALYs. Therefore, clinical guidelines such as these which promote improved treatment and prevention of stroke are an important contribution to achieving such increased access and cost-effective use of health resources in this country.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;See Chapter 9 in the original guideline document for a full discussion of cost analysis.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="104" OrdBy="465" ID="418" Name="Method of Guideline Validation" Type="picklist-choice"><FieldValue Value="External Peer Review" /><FieldValue Value="Internal Peer Review" /></Field><Field FieldID="130" OrdBy="470" ID="419" Name="Description of Method of Guideline Validation" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Consultation&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Public consultation about the draft document was undertaken over one month from February to March 2010. A specific feedback form was circulated via the Australian Stroke Coalition and members of the expert working group (EWG) and advisory group to relevant professional bodies, stroke clinical networks, consumers and consumer organisations. A public notice was published in The Australian newspaper (1 February 2010) in line with National Health and Medical Research Council (NHMRC) requirements. The draft document was also posted on the National Stroke Foundation website.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Over 460 individual comments covering a wide range of topics were received from 77 individuals, groups or organisations. Feedback received was initially considered by the NSF project team with minor amendments such as formatting or spelling reviewed and actioned. Other feedback was forwarded to relevant members of the EWG depending on topic areas and suggested responses developed. All comments and suggested responses were collated and circulated to the full EWG for consideration and discussion, with several topics being further discussed during subsequent teleconferences. Informal consensus processes were used to modify any recommendations.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;A significant number of the comments received during consultation related to the structure of the document, the size of some of the chapters and the ambiguity of some the recommendations. As a result of the feedback, significant structural changes to the order of contents of the guidelines were made. Other minor rewording and reformatting was also carried out. The sequencing of the recommendations was also reviewed and modified where appropriate.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Several topics received significantly more feedback than others and the EWG's responses are listed below:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Acute blood pressure therapy: recommendation specific to intracranial haemorrhage (ICH) added &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Behavioural management: further section added to expand this information &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Cognitive communication deficits: further section added to expand this information &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Contracture: revision of preamble regarding prolonged stretches and relevant recommendation &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Loss of sensation: revision of preamble and recommendations &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Neurointervention: rewording of recommendation regarding mechanical retrieval devices &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Spasticity: revision of preamble &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Transient ischaemic attack (TIA) management: revision of both organisation and clinical management preambles and minor changes to recommendations &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;Minor changes were also made to aphasia, cognition, incontinence, thrombolysis and dysphagia. For other topics, apart from a change in order and minor wording changes, none of the recommendations were significantly changed after feedback from consultation. Five questions, modified from key questions included in the Guidelines Implementability Tool, were also included in the consultation feedback form to provide general feedback. This feedback was used by the National Stroke Foundation (NSF) project team when reviewing and updating the draft document. Recommendations that were unclear or ambiguous were reworded. A medical editor also reviewed the guidelines to ensure that there was consistency in the language used and the presentation of the evidence.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;A letter of reply outlining the EWG's responses was sent to all individuals and organisations who provided feedback during the public consultation period. A list of individuals, groups or organisations who provided feedback during the consultation process can be obtained from the NSF.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The updated guideline document underwent one final round of peer review by international experts in the field of stroke and guideline development.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Feedback received was initially reviewed by the NSF project team and the EWG co-chairs and minor changes were made (slight wording changes to several recommendations). The final document was circulated to the EWG for sign-off and then submitted to the NHMRC for consideration of approval.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;These guidelines were approved by the Chief Executive Officer of the NHMRC on 3rd August 2010, under Section 14A of the National Health and Medical Research Council Act 1992. In approving these guidelines the NHMRC considers that they meet the NHMRC standard for clinical practice guidelines.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="420" OrdBy="500" Name="Recommendations"><Field FieldID="151" OrdBy="505" ID="421" Name="Major Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The grades of recommendations (A-D and good practice point [GPP]) are defined at the end of the &quot;Major Recommendations&quot; field.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Nutrition and Hydration&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;All stroke patients should have their hydration status assessed, monitored and managed. Appropriate fluid supplementation should be used to treat or prevent dehydration. (&lt;strong&gt;Grade B&lt;/strong&gt; [Kelly et al., 2004; Bhalla et al., 2000; Whelan, 2001; Hodgkinson, Evans, &amp;amp; Wood, 2003; Challiner et al., 1994])&lt;/p&gt;&#xD;&#xA;&lt;p&gt;All patients with stroke should be screened for malnutrition. (&lt;strong&gt;Grade B&lt;/strong&gt; [Martineau et al., 2005; Dennis et al., &quot;Routine oral,&quot; 2005])&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Patients who are at risk of malnutrition, including those with dysphagia, should be referred to a dietitian for assessment and ongoing management. (&lt;strong&gt;GPP&lt;/strong&gt;)&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Screening and assessment of nutritional status should include the use of validated nutritional assessment tools or measures. (&lt;strong&gt;Grade B&lt;/strong&gt; [DAA Malnutrition Guideline Steering Committee, 2009])&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Nutritional supplementation should be offered to people whose nutritional status is poor or deteriorating. (&lt;strong&gt;Grade A&lt;/strong&gt; [Milne, Avenell, &amp;amp; Potter, 2006])&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Nasogastric tube feeding is the preferred method during the first month post-stroke for people who do not recover a functional swallow. (&lt;strong&gt;Grade B&lt;/strong&gt; [Dennis et al., &quot;Effect of timing,&quot; 2005])&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Food intake should be monitored for all people with acute stroke. (&lt;strong&gt;GPP&lt;/strong&gt;)&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Poor Oral Hygiene&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;All patients, particularly those with swallowing difficulties, should have assistance and/or education to maintain good oral and dental (including dentures) hygiene. (&lt;strong&gt;GPP&lt;/strong&gt;)&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Staff or carers responsible for the care of patients disabled by stroke (in hospital, in residential care and in home care settings) can be trained in assessment and management of oral hygiene. (&lt;strong&gt;Grade C&lt;/strong&gt; [Brady et al., 2006])&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Spasticity&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Interventions to decrease spasticity other than an early comprehensive therapy program should NOT be routinely provided for people who have mild to moderate spasticity (i.e., spasticity that does not interfere with a stroke survivor&amp;rsquo;s activity or personal care). (&lt;strong&gt;GPP&lt;/strong&gt;)&lt;/p&gt;&#xD;&#xA;&lt;p&gt;In stroke survivors who have persistent moderate to severe spasticity (i.e., spasticity that interferes with activity or personal care):&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Botulinum toxin A should be trialled in conjunction with rehabilitation therapy which includes setting clear goals (&lt;strong&gt;Grade B&lt;/strong&gt; [Rosales &amp;amp; Chua-Yap, 2008; Elia et al., 2009; Garces et al., 2006]) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Electrical stimulation and/or electromyographic (EMG) biofeedback can be used. (&lt;strong&gt;Grade C&lt;/strong&gt; [Yan &amp;amp; Hui-Chan, 2009; Bakhtiary &amp;amp; Fatemy, 2008; Hara, Ogawa, &amp;amp; Muraoka, 2006; Swaan, van Wieringen, &amp;amp; Fokkema, 1974]) &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Contracture&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Conventional therapy (i.e., early tailored interventions) should be provided for stroke survivors at risk of or who have developed contracture. (&lt;strong&gt;GPP&lt;/strong&gt;)&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For stroke survivors at risk of or who have developed contractures and are undergoing comprehensive rehabilitation, the routine use of splints or prolonged positioning of muscles in a lengthened position is NOT recommended. (&lt;strong&gt;Grade B&lt;/strong&gt; [Turton &amp;amp; Britton, 2005; Horsley, Herbert, &amp;amp; Ada, 2007; Gustafsson &amp;amp; McKenna, 2006; B&amp;uuml;rge et al., 2008; Lannin &amp;amp; Herbert, 2003; Harvey et al., 2006; Rydwik, Eliasson, &amp;amp; Akner, 2006; Lannin, Novak, &amp;amp; Cusick, 2007])&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Overhead pulley exercise should NOT be used routinely to maintain range of motion of the shoulder. (&lt;strong&gt;Grade C&lt;/strong&gt; [Kumar et al., 1990])&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Serial casting can be used to reduce severe, persistent contracture when conventional therapy has failed. (&lt;strong&gt;GPP&lt;/strong&gt;)&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Subluxation&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For people with severe weakness who are at risk of developing a subluxed shoulder, management should include one or more of the following interventions:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Electrical stimulation (&lt;strong&gt;Grade B&lt;/strong&gt; [Ada &amp;amp; Foongchomcheay, 2002]) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Firm support devices (&lt;strong&gt;GPP&lt;/strong&gt;) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Education and training for the patient, family/carer and clinical staff on how to correctly handle and position the affected upper limb. (&lt;strong&gt;GPP&lt;/strong&gt;) &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;For people who have developed a subluxed shoulder, management may include firm support devices to prevent further subluxation. (&lt;strong&gt;Grade C&lt;/strong&gt; [Ada, Foongchomcheay, &amp;amp; Canning, 2005])&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Pain&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Shoulder Pain&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For people with severe weakness who are at risk of developing shoulder pain, management may include:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Shoulder strapping (&lt;strong&gt;Grade B&lt;/strong&gt; [Ada, Foongchomcheay &amp;amp; Canning, 2005; Griffin &amp;amp; Bernhardt, 2006]) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Interventions to educate staff, carers and people with stroke about preventing trauma. (&lt;strong&gt;GPP&lt;/strong&gt;) &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;For people who develop shoulder pain, management should be based on evidence-based interventions for acute musculoskeletal pain. (&lt;strong&gt;GPP&lt;/strong&gt;)&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The routine use of the following interventions is NOT recommended for people who have already developed shoulder pain:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Corticosteroid injections (&lt;strong&gt;Grade C&lt;/strong&gt; [Snels et al., 2000]) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Ultrasound. (&lt;strong&gt;Grade C&lt;/strong&gt; [Inaba &amp;amp; Piorkowski, 1972]) &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Central Post-stroke Pain (CPSP)&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;People with stroke found to have unresolved CPSP should receive a trial of:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Tricyclic antidepressants (e.g., amitriptyline first) followed by other tricyclic agents or venlafaxine (&lt;strong&gt;Grade B&lt;/strong&gt; [Saarto &amp;amp; Wiffen, 2007]) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Anticonvulsants (e.g., carbamazepine) (&lt;strong&gt;Grade C&lt;/strong&gt; [Wiffen et al., 2005]) &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;Any patient whose CPSP is not controlled within a few weeks should be referred to a specialist pain management team. (&lt;strong&gt;GPP&lt;/strong&gt;)&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Swelling of the Extremities&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For people who are immobile, management can include the following interventions to prevent swelling in the hand and foot:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Dynamic pressure garments (&lt;strong&gt;Grade C&lt;/strong&gt; [Gracies et al., 2000]) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Electrical stimulation (&lt;strong&gt;Grade C&lt;/strong&gt; [Faghri &amp;amp; Rodgers, 1997]) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Elevation of the limb when resting (&lt;strong&gt;GPP&lt;/strong&gt;) &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;For people who have swollen extremities, management can include the following interventions to reduce swelling in the hand and foot:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Dynamic pressure garments (&lt;strong&gt;Grade C&lt;/strong&gt; [Gracies et al., 2000]) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Electrical stimulation (&lt;strong&gt;Grade C&lt;/strong&gt; [Faghri &amp;amp; Rodgers, 1997]) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Continuous passive motion with elevation (&lt;strong&gt;Grade D&lt;/strong&gt; [Giudice, 1990]) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Elevation of the limb when resting (&lt;strong&gt;GPP&lt;/strong&gt;) &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Loss of Cardiorespiratory Fitness&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Rehabilitation should include interventions aimed at increasing cardiorespiratory fitness once patients have sufficient strength in the large lower limb muscle groups. (&lt;strong&gt;Grade A&lt;/strong&gt; [Pang et al., 2006; Saunders et al., 2009])&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Patients should be encouraged to undertake regular, ongoing fitness training. (&lt;strong&gt;GPP&lt;/strong&gt;)&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Fatigue&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Therapy for stroke survivors with fatigue should be organised for periods of the day when they are most alert. (&lt;strong&gt;GPP&lt;/strong&gt;)&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Stroke survivors and their families/carers should be provided with information and education about fatigue including potential management strategies such as exercise, establishing good sleep patterns, and avoidance of sedating drugs and excessive alcohol. (&lt;strong&gt;GPP&lt;/strong&gt;)&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Incontinence&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Urinary Incontinence&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;All stroke survivors with suspected urinary continence difficulties should be assessed by trained personnel using a structured functional assessment. (&lt;strong&gt;Grade B&lt;/strong&gt; [Martin et al., 2006; Thomas et al., 2008])&lt;/p&gt;&#xD;&#xA;&lt;p&gt;A portable bladder ultrasound scan should be used to assist in diagnosis and management of urinary incontinence. (&lt;strong&gt;Grade B&lt;/strong&gt; [Martin et al., 2006])&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Stroke survivors with confirmed continence difficulties should have a continence management plan formulated, documented, implemented and monitored. (&lt;strong&gt;Grade C&lt;/strong&gt; [Thomas et al., 2008])&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The use of indwelling catheters should be avoided as an initial management strategy except in acute urinary retention. (&lt;strong&gt;GPP&lt;/strong&gt;)&lt;/p&gt;&#xD;&#xA;&lt;p&gt;A community continence management plan should be developed with the stroke survivor and family/carer prior to discharge and should include information on accessing continence resources and appropriate review in the community. (&lt;strong&gt;GPP&lt;/strong&gt;)&lt;/p&gt;&#xD;&#xA;&lt;p&gt;If incontinence persists the stroke survivor should be re-assessed and referred for specialist review. (&lt;strong&gt;GPP&lt;/strong&gt;)&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For people with urge incontinence:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Anticholinergic drugs can be trialled (&lt;strong&gt;Grade B&lt;/strong&gt; [Wallace et al., 2004; Nabi et al., 2006]) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;A prompted or scheduled voiding regime program/bladder retraining should be trialled (&lt;strong&gt;GPP&lt;/strong&gt;) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;If continence is unachievable, containment aids can assist with social continence. (&lt;strong&gt;GPP&lt;/strong&gt;) &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;For people with urinary retention:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;The routine use of indwelling catheters is NOT recommended. However if urinary retention is severe, intermittent catheterisation should be used to assist bladder emptying during hospitalisation. If retention continues, intermittent catheterisation is preferable to indwelling catheterisation. (&lt;strong&gt;GPP&lt;/strong&gt;) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;If using intermittent catheterisation, a closed sterile catheterisation technique should be used in hospital. (&lt;strong&gt;Grade C&lt;/strong&gt; [Quigley &amp;amp; Riggin, 1993]) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Where management of chronic retention requires catheterisation, consideration should be given to the choice of appropriate route, urethral or suprapubic. (&lt;strong&gt;GPP&lt;/strong&gt;) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;If a stroke survivor is discharged with either intermittent or in-dwelling catheterisation, they and their family/carer will require education about management, where to access supplies and who to contact in case of problems. (&lt;strong&gt;GPP&lt;/strong&gt;) &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;For people with functional incontinence, a whole-team approach is recommended. (&lt;strong&gt;GPP&lt;/strong&gt;)&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Faecal Incontinence&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;All stroke survivors with suspected faecal continence difficulties should be assessed by trained personnel using a structured functional assessment. (&lt;strong&gt;Grade B&lt;/strong&gt; [Harari et al., 2004])&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For those with constipation or faecal incontinence, a full assessment (including a rectal examination) should be carried out and appropriate management of constipation, faecal overflow or bowel incontinence established and targeted education provided. (&lt;strong&gt;Grade B&lt;/strong&gt; [Harari et al., 2004])&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Bowel habit retraining using type and timing of diet and exploiting the gastro-colic reflex should be used for people who have bowel dysfunction. (&lt;strong&gt;Grade C&lt;/strong&gt; [Venn et al., 1992])&lt;/p&gt;&#xD;&#xA;&lt;p&gt;If continence is unachievable, containment aids can assist with social continence. (&lt;strong&gt;GPP&lt;/strong&gt;)&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Education and careful discharge planning and preparation are required for any patient discharged with bowel incontinence. (&lt;strong&gt;GPP&lt;/strong&gt;)&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Mood Disturbance&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Identification&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;All patients should be screened for depression using a validated tool. (&lt;strong&gt;GPP&lt;/strong&gt;)&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Patients with suspected altered mood (e.g., depression, anxiety, emotional lability) should be assessed by trained personnel using a standardised and validated scale. (&lt;strong&gt;Grade B&lt;/strong&gt; [Aben et al., 2002; Bennett et al., 2006; Benaim et al., 2004])&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Diagnosis should only be made following clinical interview. (&lt;strong&gt;GPP&lt;/strong&gt;)&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Prevention&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Psychological strategies (e.g., problem solving, motivational interviewing) can be used to prevent depression after stroke. (&lt;strong&gt;Grade B&lt;/strong&gt; [Hackett et al., &quot;Interventions for,&quot; 2008])&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Routine use of antidepressants to prevent post-stroke depression is NOT recommended. (&lt;strong&gt;Grade B&lt;/strong&gt; [Hackett et al., &quot;Interventions for,&quot; 2008])&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Intervention&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Antidepressants can be used for stroke patients who are depressed (following due consideration of the benefit and risk profile for the individual) and for those with emotional lability. (&lt;strong&gt;Grade B&lt;/strong&gt; [Hackett et al., &quot;Pharmaceutical,&quot; 2008])&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Psychological (cognitive-behavioural) intervention can be used for stroke patients who are depressed. (&lt;strong&gt;Grade B&lt;/strong&gt; [Hackett et al., &quot;Pharmaceutical,&quot; 2008])&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Behavioural Change&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The impact of chronic behavioural changes (irritability, aggression, perseveration, adynamia/apathy, emotional lability, disinhibition and impulsivity) on functional activities, participation and quality of life, including the impact on relationships, employment and leisure, should be assessed and addressed as appropriate over time. (&lt;strong&gt;GPP&lt;/strong&gt;)&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Stroke survivors and their families/carers should be given access to individually tailored interventions for personality and behavioural changes (e.g., participation in anger-management therapy) and rehabilitation training and support in management of complex and challenging behaviour. (&lt;strong&gt;GPP&lt;/strong&gt;)&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Deep Venous Thrombosis (DVT) or Pulmonary Embolism (PE)&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Early mobilisation and adequate hydration should be encouraged in all acute stroke patients to help prevent DVT and PE. (&lt;strong&gt;GPP&lt;/strong&gt;)&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Antiplatelet therapy should be used for people with ischaemic stroke to help prevent DVT/PE. (&lt;strong&gt;Grade A&lt;/strong&gt; [Sandercock et al., 2008])&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Low molecular weight heparin or heparin in prophylactic doses can be used with caution for selected patients with acute ischaemic stroke at high risk of DVT/PE. If low molecular weight heparin is contraindicated or not available, unfractionated heparin should be used. (&lt;strong&gt;Grade B&lt;/strong&gt; [Sandercock, Counsell, &amp;amp; Tseng, 2008; Shorr et al., 2008])&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Antithrombotic therapy is NOT recommended for the prevention of DVT/PE in haemorrhagic stroke patients. (&lt;strong&gt;GPP&lt;/strong&gt;)&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Thigh-length antithrombotic stockings are NOT recommended for the prevention of DVT/PE post-stroke. (&lt;strong&gt;Grade B&lt;/strong&gt; [Clots Trial Collaboration et al., 2009])&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;strong&gt;Pressure Care&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;All stroke survivors at risk (e.g., stroke severity, reduced mobility, diabetes, incontinence and nutritional status) should have a pressure care risk assessment and regular evaluation completed by trained personnel. (&lt;strong&gt;GPP&lt;/strong&gt;)&lt;/p&gt;&#xD;&#xA;&lt;p&gt;All stroke survivors assessed as high risk should be provided with appropriate pressure-relieving aids and strategies, including a pressure-relieving mattress as an alternative to a standard hospital mattress. (&lt;strong&gt;Grade B&lt;/strong&gt; [McInnes et al., 2008])&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Falls&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Falls risk assessment should be undertaken using a valid tool on admission to hospital. A management plan should be initiated for all those identified as at risk of falls. (&lt;strong&gt;GPP&lt;/strong&gt;)&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Multifactorial interventions in the community, including an individually prescribed exercise program, should be provided for people who are at risk of falling. (&lt;strong&gt;Grade B&lt;/strong&gt; [Gillespie et al., 2009])&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;strong&gt;Sleep Apnoea&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Continuous positive airway pressure (CPAP) or oral devices should be used for stroke survivors with sleep apnoea. (&lt;strong&gt;Grade B&lt;/strong&gt; [Giles et al., 2006; Lim et al., 2004])&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Definitions&lt;/span&gt;&lt;/strong&gt;:&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Grading of Recommendations&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;table border=&quot;1&quot; cellspacing=&quot;1&quot; summary=&quot;Table: Grades of Recommendations&quot; cellpadding=&quot;3&quot;&gt;&#xD;&#xA;    &lt;thead&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Grade&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Description&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/thead&gt;&#xD;&#xA;    &lt;tbody&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;A&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Body of evidence can be trusted to guide practice&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;B&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Body of evidence can be trusted to guide practice in most situations&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;C&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Body of evidence provides some support for recommendation(s) but care should be taken in its application&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;D&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Body of evidence is weak and recommendation must be applied with caution&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Good Practice Point (GPP)&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Recommended best practice based on clinical experience and expert opinion&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/tbody&gt;&#xD;&#xA;&lt;/table&gt;&lt;/div&gt;" /></Field><Field FieldID="138" OrdBy="515" ID="423" Name="Clinical Algorithm(s)" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;None provided&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="424" OrdBy="600" Name="Evidence Supporting the Recommendations"><Field FieldID="98" OrdBy="605" ID="425" Name="References Supporting the Recommendations" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Aben I, Verhey F, Lousberg R, Lodder J, Honig A. Validity of the beck depression inventory, hospital anxiety and depression scale, SCL-90, and hamilton depression rating scale as screening instruments for depression in stroke patients. Psychosomatics. 2002 Sep-Oct;43(5):386-93. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12297607&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Ada L, Foongchomcheay A, Canning C. Supportive devices for preventing and treating subluxation of the shoulder after  stroke. Cochrane Database Syst Rev. 2005;(1):CD003863. [46 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15674917&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Ada L, Foongchomcheay A. Efficacy of electrical stimulation in preventing or reducing subluxation of the shoulder after stroke: a meta-analysis. Aust J Physiother. 2002;48(4):257-67. [39 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12443520&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Bakhtiary AH, Fatemy E. Does electrical stimulation reduce spasticity after stroke? A randomized controlled study. Clin Rehabil. 2008 May;22(5):418-25. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=18441038&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Benaim C, Cailly B, Perennou D, Pelissier J. Validation of the aphasic depression rating scale. Stroke. 2004 Jul;35(7):1692-6. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15143288&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Bennett HE, Thomas SA, Austen R, Morris AM, Lincoln NB. Validation of screening measures for assessing mood in stroke patients. Br J Clin Psychol. 2006 Sep;45(Pt 3):367-76. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=17147102&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Bhalla A, Sankaralingam S, Dundas R, Swaminathan R, Wolfe CD, Rudd AG. Influence of raised plasma osmolality on clinical outcome after acute stroke. Stroke. 2000 Sep;31(9):2043-8. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10978027&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Brady M, Furlanetto D, Hunter RV, Lewis S, Milne V. Staff-led interventions for improving oral hygiene in patients following stroke. Cochrane Database Syst Rev. 2006;(4):CD003864. [41 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=17054189&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Burge E, Kupper D, Finckh A, Ryerson S, Schnider A, Leemann B. Neutral functional realignment orthosis prevents hand pain in patients with subacute stroke: a randomized trial. Arch Phys Med Rehabil. 2008 Oct;89(10):1857-62. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=18929013&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Challiner YC, Jarrett D, Hayward MJ, al-Jubouri MA, Julious SA. A comparison of intravenous and subcutaneous hydration in elderly acute stroke patients. Postgrad Med J. 1994 Mar;70(821):195-7. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8183752&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;CLOTS Trials Collaboration, Dennis M, Sandercock PA, Reid J, Graham C, Murray G, Venables G, Rudd A, Bowler G. Effectiveness of thigh-length graduated compression stockings to reduce the risk  of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial. Lancet. 2009 Jun 6;373(9679):1958-65. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=19477503&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;DAA Malnutrition Guideline Steering Committee. Evidence based practice guidelines for the nutritional management of malnutrition in adult patients across the continuum of care. Nutr Diet. 2009;66(Suppl 3)&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Dennis MS, Lewis SC, Warlow C, FOOD Trial Collaboration. Effect of timing and method of enteral tube feeding for dysphagic stroke patients (FOOD): a multicentre randomised controlled trial. Lancet. 2005 Feb 26-Mar 4;365(9461):764-72. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15733717&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Dennis MS, Lewis SC, Warlow C, FOOD Trial Collaboration. Routine oral nutritional supplementation for stroke patients in hospital (FOOD):  a multicentre randomised controlled trial. Lancet. 2005 Feb 26-Mar 4;365(9461):755-63. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15733716&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Elia AE, Filippini G, Calandrella D, Albanese A. Botulinum neurotoxins for post-stroke spasticity in adults: a systematic review. Mov Disord. 2009 Apr 30;24(6):801-12. [47 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=19224614&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Faghri, P D Rodgers MM. The effects of functional neuromuscular stimulation-augmented physical therapy program in the functional recovery of hemiplegic arm in stroke patients. Clin Kinesiol. 1997;51:9-15.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Garces K, McCormick A, McGahan L, Skidmore B. Botulinum toxin A in the treatment of upper and lower limb spasticity: a systematic review of randomized controlled trials. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 2006. 12 p. &lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Giles TL, Lasserson TJ, Smith BH, White J, Wright J, Cates CJ. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev. 2006;3:CD001106. [98 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16855960&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Gillespie LD, Robertson MC, Gillespie WJ, Lamb SE, Gates S, Cumming RG, Rowe BH. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2009;(2):CD007146. [264 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=19370674&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Giudice ML. Effects of continuous passive motion and elevation on hand edema. Am J Occup Ther. 1990 Oct;44(10):914-21. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=2248354&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Gracies JM, Marosszeky JE, Renton R, Sandanam J, Gandevia SC, Burke D. Short-term effects of dynamic lycra splints on upper limb in hemiplegic patients. Arch Phys Med Rehabil. 2000 Dec;81(12):1547-55. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11128888&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Griffin A, Bernhardt J. Strapping the hemiplegic shoulder prevents development of pain during rehabilitation: a randomized controlled trial. Clin Rehabil. 2006 Apr;20(4):287-95. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16719027&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Gustafsson L, McKenna K. A programme of static positional stretches does not reduce hemiplegic shoulder pain or maintain shoulder range of motion--a randomized controlled trial. Clin Rehabil. 2006 Apr;20(4):277-86. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16719026&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Hackett ML, Anderson CS, House A, Halteh C. Interventions for preventing depression after stroke. Cochrane Database Syst Rev. 2008;(3):CD003689. [162 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=18646094&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Hackett ML, Yang M, Anderson CS, Horrocks JA, House A. Pharmaceutical interventions for emotionalism after stroke. Cochrane Database Syst Rev. 2008;:CD003690.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Hara Y, Ogawa S, Muraoka Y. Hybrid power-assisted functional electrical stimulation to improve hemiparetic upper-extremity function. Am J Phys Med Rehabil. 2006 Dec;85(12):977-85. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=17117002&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Harari D, Norton C, Lockwood L, Swift C. Treatment of constipation and fecal incontinence in stroke patients: randomized controlled trial. Stroke. 2004 Nov;35(11):2549-55. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15486330&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Harvey L, de Jong I, Goehl G, Mardwedel S. Twelve weeks of nightly stretch does not reduce thumb web-space contractures in people with a neurological condition: a randomised controlled trial. Aust J Physiother. 2006;52(4):251-8. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=17132119&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Hodgkinson B, Evans D, Wood J. Maintaining oral hydration in older adults: a systematic review. Int J Nurs Pract. 2003 Jun;9(3):S19-28. [32 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12801253&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Horsley SA, Herbert RD, Ada L. Four weeks of daily stretch has little or no effect on wrist contracture after stroke: a randomised controlled trial. Aust J Physiother. 2007;53(4):239-45. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=18047458&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Inaba MK, Piorkowski M. Ultrasound in treatment of painful shoulders in patients with hemiplegia. Phys Ther. 1972 Jul;52(7):737-42. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=5034103&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Kelly J, Hunt BJ, Lewis RR, Swaminathan R, Moody A, Seed PT, Rudd A. Dehydration and venous thromboembolism after acute stroke. QJM. 2004 May;97(5):293-6. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15100423&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Kumar R, Metter EJ, Mehta AJ, Chew T. Shoulder pain in hemiplegia. The role of exercise. Am J Phys Med Rehabil. 1990 Aug;69(4):205-8. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=2383382&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Lannin NA, Herbert RD. Is hand splinting effective for adults following stroke? A systematic review and  methodologic critique of published research. Clin Rehabil. 2003 Dec;17(8):807-16. [30 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14682551&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Lannin NA, Novak I, Cusick A. A systematic review of upper extremity casting for children and adults with central nervous system motor disorders. Clin Rehabil. 2007 Nov;21(11):963-76. [49 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=17984149&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Lim J, Lasserson TJ, Fleetham J, Wright J. Oral appliances for obstructive sleep apnoea. Cochrane Database Syst Rev. 2004;(4):CD004435. [70 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15495109&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Martin JL, Williams KS, Abrams KR, Turner DA, Sutton AJ, Chapple C, Assassa RP, Shaw C, Cheater F. Systematic review and evaluation of methods of assessing urinary incontinence. Health Technol Assess. 2006 Feb;10(6):1-132, iii-iv. [224 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16487456&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Martineau J, Bauer JD, Isenring E, Cohen S. Malnutrition determined by the patient-generated subjective global assessment is  associated with poor outcomes in acute stroke patients. Clin Nutr. 2005 Dec;24(6):1073-7. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16213064&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;McInnes E, Bell-Syer SE, Dumville JC, Legood R, Cullum NA. Support surfaces for pressure ulcer prevention. Cochrane Database Syst Rev. 2008;(4):CD001735. [116 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=18843621&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Milne AC, Avenell A, Potter J. Meta-analysis: protein and energy supplementation in older people. Ann Intern Med. 2006 Jan 3;144(1):37-48. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16389253&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Nabi G, Cody JD, Ellis G, Herbison P, Hay-Smith J. Anticholinergic drugs versus placebo for overactive bladder syndrome in adults. Cochrane Database Syst Rev. 2006;(4):CD003781. [128 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=17054185&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Pang MY, Eng JJ, Dawson AS, Gylfadottir S. The use of aerobic exercise training in improving aerobic capacity in individuals with stroke: a meta-analysis. Clin Rehabil. 2006 Feb;20(2):97-111. [84 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16541930&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Quigley PA, Riggin OZ. A comparison of open and closed catheterization techniques in rehabilitation patients. Rehabil Nurs. 1993 Jan-Feb;18(1):26-9, 33. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8430260&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Rosales RL, Chua-Yap AS. Evidence-based systematic review on the efficacy and safety of botulinum toxin-A  therapy in post-stroke spasticity. J Neural Transm. 2008;115(4):617-23. [20 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=18322637&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Rydwik E, Eliasson S, Akner G. The effect of exercise of the affected foot in stroke patients--a randomized controlled pilot trial. Clin Rehabil. 2006 Aug;20(8):645-55. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16944822&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev. 2007;(4):CD005454. [134 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=17943857&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Sandercock PA, Counsell C, Gubitz GJ, Tseng MC. Antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev. 2008;(3):CD000029. [77 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=18646056&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Sandercock PA, Counsell C, Tseng MC. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke. Cochrane Database Syst Rev. 2008;(3):CD000119. [45 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=18646059&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Saunders DH, Greig CA, Mead GE, Young A. Physical fitness training for stroke patients. Cochrane Database Syst Rev. 2009;(4):CD003316. [269 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=19821305&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Shorr AF, Jackson WL, Sherner JH, Moores LK. Differences between low-molecular-weight and unfractionated heparin for venous thromboembolism prevention following ischemic stroke: a metaanalysis. Chest. 2008 Jan;133(1):149-55. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=17925410&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Snels IA, Beckerman H, Twisk JW, Dekker JH, Peter De Koning, Koppe PA, Lankhorst GJ, Bouter LM. Effect of triamcinolone acetonide injections on hemiplegic shoulder pain : A randomized clinical trial. Stroke. 2000 Oct;31(10):2396-401. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11022070&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Swaan D, van Wieringen PC, Fokkema SD. Auditory electromyographic feedback therapy to inhibit undesired motor activity. Arch Phys Med Rehabil. 1974 Jun;55(6):251-4. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=4842769&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Thomas LH, Cross S, Barrett J, French B, Leathley M, Sutton CJ, Watkins C. Treatment of urinary incontinence after stroke in adults. Cochrane Database Syst Rev. 2008;(1):CD004462. [42 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=18254050&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Turton AJ, Britton E. A pilot randomized controlled trial of a daily muscle stretch regime to prevent contractures in the arm after stroke. Clin Rehabil. 2005 Sep;19(6):600-12. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16180595&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Venn MR, Taft L, Carpentier B, Applebaugh G. The influence of timing and suppository use on efficiency and effectiveness of bowel training after a stroke. Rehabil Nurs. 1992 May-Jun;17(3):116-20. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=1585039&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Wallace SA, Roe B, Williams K, Palmer M. Bladder training for urinary incontinence in adults. Cochrane Database Syst Rev. 2004;(1):CD001308. [56 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14973967&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Whelan K. Inadequate fluid intakes in dysphagic acute stroke. Clin Nutr. 2001 Oct;20(5):423-8. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11534937&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Wiffen P, Collins S, McQuay H, Carroll D, Jadad A, Moore A. Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev. 2005;(3):CD001133. [86 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16034857&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Yan T, Hui-Chan CW. Transcutaneous electrical stimulation on acupuncture points improves muscle function in subjects after acute stroke: a randomized controlled trial. J Rehabil Med. 2009 Apr;41(5):312-6. &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=19363561&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="139" OrdBy="610" ID="426" Name="Type of Evidence Supporting the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The type of supporting evidence is identified and graded for each recommendation (see &quot;Major Recommendations&quot;).&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="427" OrdBy="700" Name="Benefits/Harms of Implementing the Guideline Recommendations"><Field FieldID="152" OrdBy="705" ID="428" Name="Potential Benefits" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Appropriate management of secondary complications to prevent or to reduce impairments from stroke. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;A systematic approach to resolving the barriers that delay early stroke care and the implementation of geographically appropriate models of hyper-acute care should help achieve higher thrombolysis rates and improved access to stroke unit care across Australia. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;The use of pathways or protocols has been found to reduce hospital delays for acute care in several, mostly non-randomised studies. Such pathways ensure that patients receive appropriate and timely medical and nursing assessments and crucial investigations, including prevention and appropriate management of secondary complications of stroke. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field><Field FieldID="153" OrdBy="710" ID="429" Name="Potential Harms" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Low-molecular-weight heparin (LMWH) is associated with an increase in bleeding complications and there is insufficient evidence to determine whether LMWH differs from standard heparin for clinically important endpoints such as symptomatic venous thromboembolism (VTE), intracranial haemorrhage, major extracranial haemorrhage and mortality.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="432" OrdBy="900" Name="Qualifying Statements"><Field FieldID="137" OrdBy="905" ID="433" Name="Qualifying Statements" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;This document is a general guide to appropriate practice, to be followed subject to the clinician's judgment and the patient's preference in each individual case. The guidelines are designed to provide information to assist decision-making and are based on the best evidence available at the time of development. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;The guidelines should not be seen as an inflexible recipe for stroke care, sometimes rather disparagingly called 'cookbook medicine'; rather, they provide a general guide to appropriate practice to be followed subject to the clinician's judgment and the patient's preference. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field></Section><Section SecID="434" OrdBy="1000" Name="Implementation of the Guideline"><Field FieldID="131" OrdBy="1010" ID="436" Name="Description of Implementation Strategy" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Using the Guidelines&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The primary goal of these guidelines is to help healthcare workers improve the quality and effectiveness of the care they provide.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Guidelines differ from clinical or care pathways (also referred to as critical pathways, care paths, integrated care pathways, case management plans, clinical care pathways or care maps). Guidelines are an overview of the current best evidence translated into clinically relevant statements. Care pathways are based on best practice guidelines but provide a local link between the guidelines and their use.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;In considering implementation of these guidelines at a local level, health professionals are encouraged to identify the barriers and facilitators to evidence-based care within their environment to determine the best strategy for local needs. Where change is required, initial and ongoing education is essential and is relevant to all recommendations in these guidelines.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Implementation&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Reviewing the evidence and developing evidence-based recommendations for care are only the first steps to ensuring that evidence-based care is available. Following publication, the guidelines must be disseminated to all those involved in stroke care, who will then identify ways in which the guidelines may be taken up at a local level.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Strategies by which guidelines can be disseminated and implemented include:&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Distribution of education materials, for example, guidelines will be emailed to stroke clinicians via existing stroke networks. Concise guidelines for the majority of disciplines including general practitioners, nurses and doctors are planned. A link to the guidelines will be available on the National Stroke Foundation (NSF) website and will be sent to all appropriate universities, colleges, associations, societies and other professional organisations. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Educational meetings, for example, interdisciplinary conferences or internet-based web conferences. Resources will be developed to aid workshop facilitators identify barriers and solutions in the implementation phase. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Educational outreach visits. A peer support model using centres viewed as champions in aspects of acute stroke management may be used in collaboration with national audit results. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Key opinion leaders. Educational resources will utilise key opinion leaders. It is also planned to have local champions facilitate workshops in their local areas. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Audit and feedback. Data from the National Stroke Audits will be fundamental to the implementation of these guidelines. A copy of relevant indicators covering organisation of care and clinical care will be available from the NSF along with key audit reports (see Appendix 4 in the original guideline document). &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Reminders. Electronic reminders should be used once local teams have identified key areas of quality improvement activities and commenced planned strategies. &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;The NSF strongly recommends a systematic approach to identifying gaps in service delivery, understanding local barriers or enablers to reducing those gaps and developing a clear plan of action to improve stroke services. The NSF has developed a comprehensive quality improvement (QI) program (known as StrokeLink) offering outreach visits by NSF staff using interactive educational formats linked to audit and feedback and local consensus processes. Implementation issues also need to consider the barriers to delivering services to Aboriginal and Torres Strait Islander (ATSI) people and develop models of stroke care that address local cultural and geographical needs.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Existing resources and networks (see Appendix 2 in the original guideline document) can also support implementation of these stroke guidelines.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="117" OrdBy="1015" ID="437" Name="Implementation Tools" Type="picklist-many"><FieldValue Value="Foreign Language Translations" /><FieldValue Value="Patient Resources" /><FieldValue Value="Quick Reference Guides/Physician Guides" /></Field></Section><Section SecID="439" OrdBy="1100" Name="Institute of Medicine (IOM) National Healthcare Quality Report Categories"><Field FieldID="50" OrdBy="1105" ID="440" Name="IOM Care Need" Type="picklist-many"><FieldValue Value="Getting Better" /><FieldValue Value="Living with Illness" /><FieldValue Value="Staying Healthy" /></Field><Field FieldID="51" OrdBy="1110" ID="441" Name="IOM Domain" Type="picklist-many"><FieldValue Value="Effectiveness" /><FieldValue Value="Patient-centeredness" /></Field></Section><Section SecID="442" OrdBy="1200" Name="Identifying Information and Availability"><Field FieldID="97" OrdBy="1201" ID="392" Name="Bibliographic Source(s)" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Managing complications. In: Clinical guidelines for stroke management 2010. Melbourne (Australia): National Stroke Foundation; 2010 Sep. p. 96-111.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="124" OrdBy="1205" ID="443" Name="Adaptation" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not applicable: The guideline was not adapted from another source.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="128" OrdBy="1215" ID="445" Name="Date Released" Type="text"><FieldValue Value="2007 Oct (revised 2010 Sep)" /></Field><Field FieldID="158" OrdBy="1225" ID="447" Name="Guideline Developer(s)" Type="orglist-p"><FieldValue Value="National Stroke Foundation (Australia) - Nonprofit Organization" /></Field><Field FieldID="125" OrdBy="1235" ID="449" Name="Source(s) of Funding" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Australian Government Department of Health and Ageing&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="126" OrdBy="1240" ID="450" Name="Guideline Committee" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Expert Working Group&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="127" OrdBy="1245" ID="451" Name="Composition of Group That Authored the Guideline" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;em&gt;Group Members&lt;/em&gt;: Assoc Prof Louise Ada, Physiotherapist, University of Sydney; Dr Beata Bajorek, Pharmacist, University of Sydney and Royal North Shore Hospital; Prof Alan Barber, Neurologist, Auckland City Hospital; Dr Christopher Beer, Geriatrician/clinical pharmacologist, University of Western Australia, Royal Perth and Mercy Hospitals; Assoc Prof Julie Bernhardt (co-chair), Physiotherapist, National Stroke Research Institute; Dr Geoff Boddice, Clinical Neuropsychologist/Clinical Psychologist, University of Queensland and Ipswich Hospital; Ms Brenda Booth, Consumer, Working Aged Group with Stroke, NSW; Assoc Prof Sandy Brauer, Physiotherapist, University of Queensland; Ms Louise Corben, Occupational Therapist, Monash Medical Centre and Bruce Lefroy Centre (Murdoch Childrens Research Institute); Prof Maria Crotty, Rehabilitation Specialist, Repatriation General Hospital; Prof Tricia Desmond, Neuroradiologist, Royal Melbourne Hospital; Ms Cindy Dilworth, Speech Pathologist, Royal Brisbane Hospital; Dr Steven Faux, Rehabilitation Physician, St Vincent's Hospital, Sydney; Prof Jonathan Golledge, Vascular Surgeon, Townsville Hospital; Dr Louise Gustafsson, Occupational Therapist, University of Queensland; Dr Hugh Grantham, Medical Director, SA Ambulance Service; Dr Deborah Hersh, Speech Pathologist, Australian Aphasia Association; Ms Sue-Ellen Hogg, Speech Pathologist, Port Kembla Hospital; Mr Kelvin Hill, Manager, Guidelines Program, National Stroke Foundation; Ms Louise-Anne Jordan, Manager Clinical Service Delivery, Hunter Stroke Service; Assoc Prof Lynette Joubert, Social Worker, The University of Melbourne; Prof Justin Kenardy, Clinical Psychologist, University of Queensland; Dr Jonathan Knott, Emergency Physician, Royal Melbourne Hospital; Dr Erin Lalor, Chief Executive Officer, National Stroke Foundation; Dr Elaine Leung, General Practitioner, Adelaide; Prof Richard Lindley (co-chair), Geriatrician, University of Sydney; Ms Judy Martineau, Nutrition Consultant, Wesley Hospital; Prof Sandy Middleton, Director, Nursing Research Institute, St Vincent's &amp;amp; Mater Health Sydney, Australian Catholic University, Director, National Centre for Clinical Outcomes Research (NaCCOR), Nursing and Midwifery; Dr Ramu Nachiappan, General Practitioner, Broken Hill; Prof Mark Nelson, General Practitioner, University of Tasmania; Prof Lin Perry, Professor of Nursing Research and Practice Development, University of Technology, Prince of Wales Hospital and Sydney Eye Hospital; Ms Fiona Simpson, Dietitian and Senior Research Fellow, Royal North Shore Hospital; Ms Trish Spreadborough, Nurse Unit Manager, Rehabilitation, Redcliffe Hospital; Ms Leah Wright, Senior Project Officer, Guidelines Program, National Stroke Foundation&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="147" OrdBy="1250" ID="452" Name="Financial Disclosures/Conflicts of Interest" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;All members of the Expert Working Group (EWG) completed and signed a declaration of potential conflicts of interest. Members also declared any potential conflicts at the beginning of each meeting throughout the development process. Most had no perceived conflicts. The reasons for potential conflicts primarily involved receiving money from non-commercial and commercial organisations specifically for undertaking clinical research. This was expected given the expertise of members in clinical research. Only a small number of members had received financial support from commercial companies for consultancy or lecturing. A policy of managing conflicts of interest was used during the process.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="159" OrdBy="1255" ID="453" Name="Guideline Endorser(s)" Type="orglist"><FieldValue Value="Australian and New Zealand Society for Geriatric Medicine - Medical Specialty Society" /><FieldValue Value="Australian College for Emergency Medicine - Medical Specialty Society" /><FieldValue Value="Australian College of Rural and Remote Medicine - Professional Association" /><FieldValue Value="Australian Physiotherapy Association - Medical Specialty Society" /><FieldValue Value="beyondblue: the national depression initiative - Nonprofit Organization" /><FieldValue Value="Carers Australia - Professional Association" /><FieldValue Value="Continence Foundation of Australia - Professional Association" /><FieldValue Value="Council of Ambulance Authorities (Australia) - Professional Association" /><FieldValue Value="Dietitians Association of Australia - Professional Association" /><FieldValue Value="Internal Medicine Society of Australia and New Zealand - Medical Specialty Society" /><FieldValue Value="Occupational Therapy Australia - Professional Association" /><FieldValue Value="Pharmacy Guild of Australia - For Profit Organization" /><FieldValue Value="Royal Australian and New Zealand College of Psychiatrists - Professional Association" /><FieldValue Value="Royal Australian College of General Practitioners - Professional Association" /><FieldValue Value="Royal College of Nursing, Australia - Professional Association" /><FieldValue Value="Speech Pathology Australia - Medical Specialty Society" /><FieldValue Value="Stroke Society of Australasia - Disease Specific Society" /></Field><Field FieldID="120" OrdBy="1256" ID="393" Name="Guideline Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the guideline.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;This guideline updates a previous version: Prevention and management of complications. In: National Stroke Foundation. Clinical guidelines for acute stroke management. Melbourne (Australia): National Stroke Foundation; 2007 Oct. p. 39-42.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="118" OrdBy="1260" ID="454" Name="Guideline Availability" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Electronic copies: Available in Portable Document Format (PDF) from the &lt;a href=&quot;http://www.strokefoundation.com.au/clinical-guidelines&quot; title=&quot;NSF Australia Web site&quot;&gt;National Stroke Foundation (Australia) Web site&lt;/a&gt;.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Print copies: Available from the National Stroke Foundation (Australia), Level 7, 461 Bourke Street, Melbourne Victoria 3000, Australia.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="119" OrdBy="1265" ID="455" Name="Availability of Companion Documents" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The following are available:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Clinical guidelines for stroke management 2010 recommendations. Melbourne (Australia): National Stroke Foundation; 2010. 30 p. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Ten things to know about the clinical guidelines for stroke management 2010. Melbourne (Australia): National Stroke Foundation; 2010. 1 p. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;Electronic copies: Available in Portable Document Format (PDF) from the &lt;a href=&quot;http://www.strokefoundation.com.au/clinical-guidelines&quot; title=&quot;NSF Web site&quot;&gt;National Stroke Foundation (Australia) Web site&lt;/a&gt;.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Also, the following concise guidelines are available:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Clinical guidelines for stroke management: A quick guide for general practitioners. 2010. 8 p. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Clinical guidelines for stroke management: A quick guide for occupational therapy. 2010. 10 p. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Clinical guidelines for stroke management: A quick guide for dietetics. 2010. 5 p. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Clinical guidelines for stroke management: A quick guide for physiotherapy. 2010. 8 p. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Clinical guidelines for stroke management: A quick guide for psychology. 2010. 8 p. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Clinical guidelines for stroke management: A quick guide for social work. 2010. 7 p. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;Electronic copies: Available in Portable Document Format (PDF) from the &lt;a href=&quot;http://www.strokefoundation.com.au/concise&quot; title=&quot;NSF Australia Web site&quot;&gt;National Stroke Foundation (Australia) Web site&lt;/a&gt;.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Print copies: Available from the National Stroke Foundation (Australia), Level 7, 461 Bourke Street, Melbourne Victoria 3000, Australia.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="143" OrdBy="1275" ID="457" Name="Patient Resources" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The following is available:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;All about stroke. Melbourne (Australia): National Stroke Foundation; 2010. 5 p. Available in Portable Document Format (PDF) in English, Vietnamese, Chinese, Arabic, Italian and Greek from the &lt;a href=&quot;http://www.strokefoundation.com.au/translated-resources&quot; title=&quot;NSA Australia Web site&quot;&gt;National Stroke Foundation (Australia) Web site&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;Print copies: Available from the National Stroke Foundation (Australia), Level 7, 461 Bourke Street, Melbourne Victoria 3000, Australia.&lt;/p&gt;&#xD;&#xA;&lt;p class=&quot;Disclaimer&quot;&gt;Please note: This patient information is intended to provide health professionals with information to share with their patients to help them better understand their health and their diagnosed disorders. By providing access to this patient information, it is not the intention of NGC to provide specific medical advice for particular patients. Rather we urge patients and their representatives to review this material and then to consult with a licensed health professional for evaluation of treatment options suitable for them as well as for diagnosis and answers to their personal medical questions. This patient information has been derived and prepared from a guideline for health care professionals included on NGC by the authors or publishers of that original guideline. The patient information is not reviewed by NGC to establish whether or not it accurately reflects the original guideline's content.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="142" OrdBy="1280" ID="458" Name="NGC Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This NGC summary was completed by ECRI Institute on December 1, 2008. The information was verified by the guideline developer on December 4, 2008. This summary was updated by ECRI Institute on July 27, 2010 following the FDA drug safety communication on Heparin. This NGC summary was updated by ECRI Institute on January 27, 2011. This summary was updated by ECRI Institute on March 7, 2014 following the U.S. Food and Drug Administration advisory on Low Molecular Weight Heparins.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="141" OrdBy="1290" ID="460" Name="Copyright Statement" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="99999" OrdBy="99999" Name="Disclaimer"><Field FieldID="99999" OrdBy="99999" ID="99999" Name="NGC Disclaimer" Type="text"><FieldValue Value="&lt;p&gt;The National Guideline Clearinghouse (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at &lt;a href=&quot;/about/inclusion-criteria.aspx&quot;&gt;http://www.guideline.gov/about/inclusion-criteria.aspx&lt;/a&gt;.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Readers with questions regarding guideline content are directed to contact the guideline developer.&lt;/p&gt;" /></Field></Section></Version>
